mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Nature Cell Biology2015Vol. 17(9), pp. 1205–1217
Citations Over TimeTop 1% of 2015 papers
Nicolás Herranz, Suchira Gallage, Massimiliano Mellone, Torsten Wüestefeld, Sabrina Klotz, Christopher J. Hanley, Selina Raguz, Juan Carlos Acosta, Andrew J. Innes, Ana Banito, Athena Georgilis, Alex Montoya, Katharina Wolter, Gopuraja Dharmalingam, Peter Faull, Thomas Carroll, Juan Pedro Martı́nez-Barberá, Pedro R. Cutillas, Florian Reisinger, Mathias Heikenwälder, Richard Miller, Dominic J. Withers, Lars Zender, Gareth J. Thomas, Jesús Gil
Related Papers
- → The mTOR–Autophagy Axis and the Control of Metabolism(2021)313 cited
- → Targeting mTOR globally in cancer: Thinking beyond rapamycin(2009)155 cited
- → Current Approaches and Future Directions for the Treatment of mTORopathies(2021)75 cited
- → Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor(2023)24 cited
- → Comprehensive Evaluation of Rapamycin’s Specificity as an mTOR Inhibitor(2022)